NEW YORK (GenomeWeb News) – Hybrigenics, a French biopharmaceutical and life science tools firm, has signed a three-year equity facility agreement with Yorkville Advisors, under which Hybrigenics could receive up to €5 million ($7.3 million).

The equity facility is subject to approval at the next extraordinary general meeting of Hybrigenics, which is expected to be called on Oct. 23, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.